Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations.
Saved in:
| Title: | Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations. |
|---|---|
| Authors: | Pügge, Stefanie, Dukic-Ott, Aleksandra, Baumgärtel, Julian, Jünger, Saskia, Bausewein, Claudia, Rémi, Constanze |
| Source: | Palliative Medicine. May2025, Vol. 39 Issue 5, p530-542. 13p. |
| Subjects: | Off-label use (Drugs), Medical protocols, Consensus (Social sciences), Home care services, Drug administration routes, Fistula, Patient safety, Research funding, Hospital nursing staff, Hospital care, Decision making in clinical medicine, Xerostomia, Itching, Hot flashes, Pharmacy information services, Hiccups, Lung diseases, Drug efficacy, Palliative medicine, Evidence-based medicine, Delphi method, Physicians, Palliative care nurses, Drooling, Gastroparesis, Drug dosage, Therapeutics, Drug administration, Adults |
| Abstract: | Background: Off-label use of drugs is an integral part of everyday clinical practice in palliative medicine. However, it is associated with many uncertainties, that is, drug therapy safety or legal issues including cost coverage. Healthcare professionals often lack time and resources for comprehensive literature search and patient-specific risk-benefit analyses. Aim: The aim of this project is to develop, evaluate and rate agreement/disagreement on treatment recommendations for off-label use in adult palliative medicine. Design: Online Delphi study with two rounds each to rate agreement/disagreement with treatment recommendations for off-label use in adult palliative medicine. An international expert panel consisting of physicians, pharmacists and nurses working in palliative care evaluated previously developed recommendations based on the best available evidence. Setting:/participants: Professionals (physicians, pharmacists, nursing staff) working in inpatient and home palliative care involved in the medication process were recruited as experts to participate. Between 64 and 75 experts participated in the first two Delphi studies. Results: A total of 64/68 recommendations on 21 drugs and 14 applications were agreed upon. Topics related to routes of administration as well as indications for sialorrhea, bronchorrhea, xerostomia, pruritus, singultus, fistula, gastroparesis and hot flashes. Recommendations that reached consensus are available to health care professionals via a free of charge database. Conclusion: For many off-label use applications, it is likely that there will be no registration studies and therefore no drug approvals in the future. The consensus-based recommendations are intended to facilitate individual treatment planning for prescribers and to enable a more reflected handling of off-label use. [ABSTRACT FROM AUTHOR] |
| Copyright of Palliative Medicine is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: Off-label use of drugs is an integral part of everyday clinical practice in palliative medicine. However, it is associated with many uncertainties, that is, drug therapy safety or legal issues including cost coverage. Healthcare professionals often lack time and resources for comprehensive literature search and patient-specific risk-benefit analyses. Aim: The aim of this project is to develop, evaluate and rate agreement/disagreement on treatment recommendations for off-label use in adult palliative medicine. Design: Online Delphi study with two rounds each to rate agreement/disagreement with treatment recommendations for off-label use in adult palliative medicine. An international expert panel consisting of physicians, pharmacists and nurses working in palliative care evaluated previously developed recommendations based on the best available evidence. Setting:/participants: Professionals (physicians, pharmacists, nursing staff) working in inpatient and home palliative care involved in the medication process were recruited as experts to participate. Between 64 and 75 experts participated in the first two Delphi studies. Results: A total of 64/68 recommendations on 21 drugs and 14 applications were agreed upon. Topics related to routes of administration as well as indications for sialorrhea, bronchorrhea, xerostomia, pruritus, singultus, fistula, gastroparesis and hot flashes. Recommendations that reached consensus are available to health care professionals via a free of charge database. Conclusion: For many off-label use applications, it is likely that there will be no registration studies and therefore no drug approvals in the future. The consensus-based recommendations are intended to facilitate individual treatment planning for prescribers and to enable a more reflected handling of off-label use. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 02692163 |
| DOI: | 10.1177/02692163251323123 |
